# Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer

> **NCT02353260** · PHASE2 · UNKNOWN · sponsor: **Wei Guo** · enrollment: 120 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DEVICE:** Ultrasound Hyperthermia
- **DRUG:** Docetaxel,Cisplatin,Fluorouracil

## Key facts

- **NCT ID:** NCT02353260
- **Lead sponsor:** Wei Guo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-03
- **Final completion:** 2017-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2015-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02353260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02353260, "Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02353260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*